Pretransplant NT-proBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients

被引:10
作者
Yeung, Stanley M. H. [1 ,2 ]
van Londen, Marco [1 ,2 ]
Nakshbandi, Uzma [1 ,2 ]
Said, M. Yusof [1 ,2 ]
Eisenga, Michele F. [1 ,2 ]
Hepkema, Bouke G. [1 ,2 ]
Nolte, Ilja M. [1 ,2 ]
Berger, Stefan P. [1 ,2 ]
de Borst, Martin H. [1 ,2 ]
Bakker, Stephan J. L. [1 ,2 ]
机构
[1] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands
[2] Univ Groningen, Groningen, Netherlands
关键词
BRAIN NATRIURETIC PEPTIDE; CONGESTIVE-HEART-FAILURE; RENAL-TRANSPLANTATION; HEMODIALYSIS-PATIENTS; CARDIAC BIOMARKERS; DYSFUNCTION; SURVIVAL; MANAGEMENT; DIAGNOSIS; DEATH;
D O I
10.1097/TP.0000000000003125
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. End-stage kidney disease and dialysis vintage are characterized by accelerated atherosclerosis, volume overload, and progressive left ventricular hypertrophy, leading to elevated N-terminal probrain natriuretic peptide (NT-proBNP) levels. Pretransplant dialysis vintage is associated with excess mortality after transplantation. We want to study whether pretransplant NT-proBNP is associated with posttransplantation mortality and if it explains the association of dialysis vintage with posttransplantation mortality in kidney transplant recipients (KTR). Methods. We measured plasma NT-proBNP on arrival at the hospital before kidney transplantation in 658 KTR between January 1995 and December 2005 in our center. Multivariable Cox regression analyses, adjusted for potential confounders, were used to prospectively study the associations of dialysis vintage and NT-proBNP with all-cause mortality. Results. During median 12.7 (7.8-15.6) years of follow-up after transplantation, 248 (37.7%) KTR died. Dialysis vintage was associated with an increased risk of posttransplant mortality in the fully adjusted model (hazard ratio [HR], 1.22; 95% confidence interval [CI], 1.03-1.43;P= 0.02), independent of potential confounders. The association weakened materially and lost significance after further adjustment for NT-proBNP (HR, 1.14; 0.96-1.34;P= 0.14). NT-proBNP was independently associated with all-cause mortality in the fully adjusted model (HR, 1.34; 1.16-1.55;P< 0.001). The association remained independent of adjustment for dialysis vintage (HR, 1.31; 1.13-1.52;P< 0.001). Conclusions. Our study shows that longer dialysis vintage is associated with a higher mortality risk in KTR, and this association might be explained for a considerable part by variation in pretransplant NT-proBNP at the time of transplantation.
引用
收藏
页码:2158 / 2165
页数:8
相关论文
共 50 条
[21]   The association of plasma NT-proBNP level and progression of diabetic kidney disease [J].
Zhao, Yuancheng ;
Zhao, Lijun ;
Wang, Yiting ;
Zhang, Junlin ;
Ren, Honghong ;
Zhang, Rui ;
Wu, Yucheng ;
Zou, Yutong ;
Tong, Nanwei ;
Liu, Fang .
RENAL FAILURE, 2023, 45 (01)
[22]   An instrumental variable approach confirms that the duration of pretransplant dialysis has a negative impact on the survival of kidney transplant recipients and quantifies the risk [J].
Fu, Rui ;
Kim, S. Joseph ;
de Oliveira, Claire ;
Coyte, Peter C. .
KIDNEY INTERNATIONAL, 2019, 96 (02) :450-459
[23]   Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients [J].
Huber, Lu ;
Lachmann, Nils ;
Niemann, Matthias ;
Naik, Marcel ;
Liefeldt, Lutz ;
Glander, Petra ;
Schmidt, Danilo ;
Halleck, Fabian ;
Waiser, Johannes ;
Brakemeier, Susanne ;
Neumayer, Hans H. ;
Schoenemann, Constanze ;
Budde, Klemens .
TRANSPLANT INTERNATIONAL, 2015, 28 (06) :710-719
[24]   NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease [J].
Maurer, Susanne J. ;
Habdank, Veronika ;
Horer, Juergen ;
Ewert, Peter ;
Tutarel, Oktay .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
[25]   Pulmonary artery diameter and NT-proBNP in patients with Covid-19: Predicting prognosis and mortality [J].
Tastemur, Mercan ;
Olcucuoglu, Esin ;
Arik, Gunes ;
Ates, Ihsan ;
Silay, Kamile .
AFRICAN HEALTH SCIENCES, 2023, 23 (02) :553-564
[26]   NT-proBNP point-of-care testing for predicting mortality in end-stage renal disease: A survival analysis [J].
Chen, Chun ;
Hsu, Yin-Chen ;
Chou, Kuang-Wei ;
Chang, Kuo-Song ;
Hsu, Ya-Hui ;
Chiu, Wei-Huai ;
Lee, Chun-Wei ;
Yang, Po-Sheng ;
Chang, Wen-Han ;
Huang, Yao-Kuang ;
Chen, Pang-Yen ;
Chen, Chien-Wei ;
Su, Yu-Jang .
HELIYON, 2024, 10 (09)
[27]   Dialysis Modality and Outcomes in Kidney Transplant Recipients [J].
Molnar, Miklos Z. ;
Mehrotra, Rajnish ;
Duong, Uyen ;
Bunnapradist, Suphamai ;
Lukowsky, Lilia R. ;
Krishnan, Mahesh ;
Kovesdy, Csaba P. ;
Kalantar-Zadeh, Kamyar .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (02) :332-341
[28]   Pulmonary Hypertension among Patients on Dialysis and Kidney Transplant Recipients [J].
Abedini, Mokhtar ;
Sadeghi, Masoumeh ;
Naini, Afsoon Emami ;
Atapour, Abdolamir ;
Golshahi, Jafar .
RENAL FAILURE, 2013, 35 (04) :560-565
[29]   NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population [J].
Ciardullo, Stefano ;
Rea, Federico ;
Cannistraci, Rosa ;
Muraca, Emanuele ;
Perra, Silvia ;
Zerbini, Francesca ;
Mortara, Andrea ;
Perseghin, Gianluca .
CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
[30]   NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease [J].
Skrzypczyk, Piotr ;
Okarska-Napierala, Magdalena ;
Pietrzak, Radoslaw ;
Pawlik, Katarzyna ;
Wascinska, Katarzyna ;
Werner, Bozena ;
Panczyk-Tomaszewska, Malgorzata .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)